Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer
06:25 EDT 15 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
BETHLEHEM, Pa., June 15, 2012 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today ...
Other Sources for this Article
More From BioPortfolio on "Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
